Gilder Gagnon Howe & Co. LLC cut its position in athenahealth, Inc. (NASDAQ:ATHN) by 74.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,817 shares of the health services provider’s stock after selling 8,053 shares during the period. Gilder Gagnon Howe & Co. LLC’s holdings in athenahealth were worth $396,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in ATHN. State Street Corp increased its position in shares of athenahealth by 3.7% in the first quarter. State Street Corp now owns 502,823 shares of the health services provider’s stock worth $56,662,000 after buying an additional 17,718 shares during the last quarter. Rockefeller Financial Services Inc. increased its position in shares of athenahealth by 13.1% in the first quarter. Rockefeller Financial Services Inc. now owns 8,445 shares of the health services provider’s stock worth $952,000 after buying an additional 975 shares during the last quarter. BlackRock Inc. increased its position in shares of athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock worth $180,286,000 after buying an additional 1,594,643 shares during the last quarter. UBS Asset Management Americas Inc. increased its position in shares of athenahealth by 14.0% in the first quarter. UBS Asset Management Americas Inc. now owns 22,931 shares of the health services provider’s stock worth $2,584,000 after buying an additional 2,820 shares during the last quarter. Finally, Teachers Advisors LLC increased its position in shares of athenahealth by 3.0% in the fourth quarter. Teachers Advisors LLC now owns 74,094 shares of the health services provider’s stock worth $7,792,000 after buying an additional 2,190 shares during the last quarter.

athenahealth, Inc. (NASDAQ:ATHN) opened at 139.16 on Friday. athenahealth, Inc. has a 12-month low of $90.11 and a 12-month high of $158.66. The company has a market cap of $5.56 billion, a PE ratio of 176.60 and a beta of 1.77. The stock has a 50 day moving average of $142.86 and a 200 day moving average of $125.37.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.39 by $0.12. The business had revenue of $301.10 million for the quarter, compared to analysts’ expectations of $298.68 million. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The company’s revenue was up 15.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.34 EPS. Equities analysts expect that athenahealth, Inc. will post $1.92 earnings per share for the current year.

WARNING: This story was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright and trademark law. The legal version of this story can be read at https://www.watchlistnews.com/athenahealth-inc-athn-shares-sold-by-gilder-gagnon-howe-co-llc/1472997.html.

A number of equities analysts have recently weighed in on ATHN shares. William Blair restated a “market perform” rating on shares of athenahealth in a research note on Friday, July 21st. Cantor Fitzgerald restated a “buy” rating and issued a $118.00 target price (down previously from $135.00) on shares of athenahealth in a research note on Thursday, April 27th. Argus started coverage on athenahealth in a research note on Friday, July 7th. They issued a “hold” rating on the stock. Citigroup Inc. restated a “buy” rating and issued a $163.00 target price (up previously from $128.00) on shares of athenahealth in a research note on Monday, June 5th. Finally, J P Morgan Chase & Co set a $136.00 target price on athenahealth and gave the stock a “hold” rating in a research note on Wednesday, July 19th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and thirteen have issued a buy rating to the company’s stock. athenahealth presently has a consensus rating of “Hold” and an average target price of $148.64.

In other news, Director Brandon H. Hull sold 800 shares of athenahealth stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $140.81, for a total transaction of $112,648.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Jonathan D. Porter sold 300 shares of athenahealth stock in a transaction on Monday, May 15th. The stock was sold at an average price of $109.48, for a total transaction of $32,844.00. The disclosure for this sale can be found here. Insiders have sold a total of 22,905 shares of company stock worth $3,120,107 in the last quarter. Corporate insiders own 3.20% of the company’s stock.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.